Crystal structure of human bleomycin hydrolase, a self- compartmentalizing cysteine protease

Paul A. O'Farrell, Fernando Gonzalez, Wenjin Zheng, Stephen Johnston, Leemor Joshua-Tor

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background: Bleomycin hydrolase (BH) is a cysteine protease that is found in all tissues in mammals as well as in many other eukaryotes and prokaryotes. Although its conserved cellular function is as yet unknown, human bleomycin hydrolase (hBH) has clinical significance in that it is thought to be the major cause of tumor cell resistance to bleomycin chemotherapy. In addition, it has been reported that an allelic variant of hBH is genetically linked to Alzheimer's disease. Results: We have determined the crystal structures of wild-type hBH and of a mutant form of the enzyme. The overall structure is very similar to that of the previously determined yeast homolog, however, there is a striking difference in the charge distribution. The central channel, which has a strong positive electrostatic potential in the yeast protein, is slightly negative in hBH. We have determined that hBH does not have the DNA-binding activity of the yeast protein and that the enzyme is localized to the cytoplasm. Conclusions: The difference in charge distribution between the yeast and human BH enzymes is most likely responsible for the difference in DNA-binding activity. Nevertheless, the C-terminal autoprocessing activity and the role of the C terminus as a determinant for peptidase activity are conserved between the yeast and human forms. The structure of hBH suggests that the putative Alzheimer's disease linked variation does not directly alter the intrinsic peptidase activity. Rather, the position of the mutation suggests that it could affect interactions with another protein, which may modulate peptidase activity through repositioning of the C terminus.

Original languageEnglish (US)
Pages (from-to)619-627
Number of pages9
JournalStructure
Volume7
Issue number6
DOIs
StatePublished - Jun 1999
Externally publishedYes

Fingerprint

Cysteine Proteases
Peptide Hydrolases
Fungal Proteins
Yeasts
Alzheimer Disease
Enzymes
bleomycin hydrolase
DNA
Bleomycin
Eukaryota
Static Electricity
Mammals
Cytoplasm
Drug Therapy
Mutation

Keywords

  • Alzheimer's disease
  • Bleomycin hydrolase
  • Cancer
  • Crystal structure
  • Drug resistance
  • Nucleic acid binding

ASJC Scopus subject areas

  • Molecular Biology
  • Structural Biology

Cite this

Crystal structure of human bleomycin hydrolase, a self- compartmentalizing cysteine protease. / O'Farrell, Paul A.; Gonzalez, Fernando; Zheng, Wenjin; Johnston, Stephen; Joshua-Tor, Leemor.

In: Structure, Vol. 7, No. 6, 06.1999, p. 619-627.

Research output: Contribution to journalArticle

O'Farrell, Paul A. ; Gonzalez, Fernando ; Zheng, Wenjin ; Johnston, Stephen ; Joshua-Tor, Leemor. / Crystal structure of human bleomycin hydrolase, a self- compartmentalizing cysteine protease. In: Structure. 1999 ; Vol. 7, No. 6. pp. 619-627.
@article{4cb47378d79145529d07a668c2407482,
title = "Crystal structure of human bleomycin hydrolase, a self- compartmentalizing cysteine protease",
abstract = "Background: Bleomycin hydrolase (BH) is a cysteine protease that is found in all tissues in mammals as well as in many other eukaryotes and prokaryotes. Although its conserved cellular function is as yet unknown, human bleomycin hydrolase (hBH) has clinical significance in that it is thought to be the major cause of tumor cell resistance to bleomycin chemotherapy. In addition, it has been reported that an allelic variant of hBH is genetically linked to Alzheimer's disease. Results: We have determined the crystal structures of wild-type hBH and of a mutant form of the enzyme. The overall structure is very similar to that of the previously determined yeast homolog, however, there is a striking difference in the charge distribution. The central channel, which has a strong positive electrostatic potential in the yeast protein, is slightly negative in hBH. We have determined that hBH does not have the DNA-binding activity of the yeast protein and that the enzyme is localized to the cytoplasm. Conclusions: The difference in charge distribution between the yeast and human BH enzymes is most likely responsible for the difference in DNA-binding activity. Nevertheless, the C-terminal autoprocessing activity and the role of the C terminus as a determinant for peptidase activity are conserved between the yeast and human forms. The structure of hBH suggests that the putative Alzheimer's disease linked variation does not directly alter the intrinsic peptidase activity. Rather, the position of the mutation suggests that it could affect interactions with another protein, which may modulate peptidase activity through repositioning of the C terminus.",
keywords = "Alzheimer's disease, Bleomycin hydrolase, Cancer, Crystal structure, Drug resistance, Nucleic acid binding",
author = "O'Farrell, {Paul A.} and Fernando Gonzalez and Wenjin Zheng and Stephen Johnston and Leemor Joshua-Tor",
year = "1999",
month = "6",
doi = "10.1016/S0969-2126(99)80083-5",
language = "English (US)",
volume = "7",
pages = "619--627",
journal = "Structure with Folding & design",
issn = "0969-2126",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - Crystal structure of human bleomycin hydrolase, a self- compartmentalizing cysteine protease

AU - O'Farrell, Paul A.

AU - Gonzalez, Fernando

AU - Zheng, Wenjin

AU - Johnston, Stephen

AU - Joshua-Tor, Leemor

PY - 1999/6

Y1 - 1999/6

N2 - Background: Bleomycin hydrolase (BH) is a cysteine protease that is found in all tissues in mammals as well as in many other eukaryotes and prokaryotes. Although its conserved cellular function is as yet unknown, human bleomycin hydrolase (hBH) has clinical significance in that it is thought to be the major cause of tumor cell resistance to bleomycin chemotherapy. In addition, it has been reported that an allelic variant of hBH is genetically linked to Alzheimer's disease. Results: We have determined the crystal structures of wild-type hBH and of a mutant form of the enzyme. The overall structure is very similar to that of the previously determined yeast homolog, however, there is a striking difference in the charge distribution. The central channel, which has a strong positive electrostatic potential in the yeast protein, is slightly negative in hBH. We have determined that hBH does not have the DNA-binding activity of the yeast protein and that the enzyme is localized to the cytoplasm. Conclusions: The difference in charge distribution between the yeast and human BH enzymes is most likely responsible for the difference in DNA-binding activity. Nevertheless, the C-terminal autoprocessing activity and the role of the C terminus as a determinant for peptidase activity are conserved between the yeast and human forms. The structure of hBH suggests that the putative Alzheimer's disease linked variation does not directly alter the intrinsic peptidase activity. Rather, the position of the mutation suggests that it could affect interactions with another protein, which may modulate peptidase activity through repositioning of the C terminus.

AB - Background: Bleomycin hydrolase (BH) is a cysteine protease that is found in all tissues in mammals as well as in many other eukaryotes and prokaryotes. Although its conserved cellular function is as yet unknown, human bleomycin hydrolase (hBH) has clinical significance in that it is thought to be the major cause of tumor cell resistance to bleomycin chemotherapy. In addition, it has been reported that an allelic variant of hBH is genetically linked to Alzheimer's disease. Results: We have determined the crystal structures of wild-type hBH and of a mutant form of the enzyme. The overall structure is very similar to that of the previously determined yeast homolog, however, there is a striking difference in the charge distribution. The central channel, which has a strong positive electrostatic potential in the yeast protein, is slightly negative in hBH. We have determined that hBH does not have the DNA-binding activity of the yeast protein and that the enzyme is localized to the cytoplasm. Conclusions: The difference in charge distribution between the yeast and human BH enzymes is most likely responsible for the difference in DNA-binding activity. Nevertheless, the C-terminal autoprocessing activity and the role of the C terminus as a determinant for peptidase activity are conserved between the yeast and human forms. The structure of hBH suggests that the putative Alzheimer's disease linked variation does not directly alter the intrinsic peptidase activity. Rather, the position of the mutation suggests that it could affect interactions with another protein, which may modulate peptidase activity through repositioning of the C terminus.

KW - Alzheimer's disease

KW - Bleomycin hydrolase

KW - Cancer

KW - Crystal structure

KW - Drug resistance

KW - Nucleic acid binding

UR - http://www.scopus.com/inward/record.url?scp=0033152757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033152757&partnerID=8YFLogxK

U2 - 10.1016/S0969-2126(99)80083-5

DO - 10.1016/S0969-2126(99)80083-5

M3 - Article

C2 - 10404591

AN - SCOPUS:0033152757

VL - 7

SP - 619

EP - 627

JO - Structure with Folding & design

JF - Structure with Folding & design

SN - 0969-2126

IS - 6

ER -